Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in PRLD — Prelude Therapeutics Inc

CIK 73124 CHICAGO, IL
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,282,392
+$1,110,982 QoQ
Shares Held
240,599
+380.0% QoQ
Ownership
0.301%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 75 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 98% Shared 2% None 0%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. PRLD ranks #263 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in PRLD

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,282,392 240,599
2026-03-31 $171,410 50,120
2025-12-31 $145,348 50,120
2025-09-30 $52,446 36,421
2025-06-30 $30,844 38,127
2025-03-31 $89,784 116,907
2024-12-31 $106,317 83,387
2024-09-30 $220,199 106,377
2024-06-30 $475,053 124,686
2024-03-31 $578,976 122,147
2023-12-31 $487,194 114,097
2023-09-30 $356,949 115,518
2023-06-30 $367,177 81,595
2023-03-31 $120,651 21,167
2022-12-31 $127,847 21,167
2022-09-30 $139,913 21,167
2022-06-30 $110,491 21,167
2022-03-31 $703,151 101,906
2021-12-31 $1,334,440 107,184
2021-09-30 $3,325,781 106,425
2021-06-30 $3,397,721 118,677
2021-03-31 $5,004,571 115,499
2020-12-31 $8,229,895 115,023